Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.1/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 35.5; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.1/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 68.0; sample size: 40.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 98.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 50.2; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 75.0; human relevance: 90.0; therapeutic relevance: 50.1; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 60.1; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 70.1; sample size: 90.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 10.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 20.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 10.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 10.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 10.0; sample size: 100.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 60.0; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 10.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 30.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 75.0/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 20.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 74.9/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 62.1; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 74.9/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 52.0; sample size: 70.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 74.9/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 29.5; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 74.9/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 34.5; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
